Pancreatic Ductal Adenocarcinoma Treatment-The Past, Present, and Future

被引：1
|
作者：
Lavu, Harish [1 ]
Yeo, Charles J. [1 ]
机构：
[1] Thomas Jefferson Univ, Biliary & Related Canc Ctr, Jefferson Pancreas, Philadelphia, PA 19107 USA
来源：
SEMINARS IN ONCOLOGY | 2015年 / 42卷 / 01期
关键词：
RANDOMIZED-CONTROLLED-TRIAL; DISTAL PANCREATECTOMY; SINGLE INSTITUTION; CANCER; PANCREATICODUODENECTOMY; RESECTION; SURVIVAL; OUTCOMES; THERAPY; RISK;
D O I：
10.1053/j.seminoncol.2014.12.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 7
页数：4
相关论文
共 50 条
  • [41] The past, present, and future of immunotherapy for endometrial adenocarcinoma
    Jones, Anna C.
    Brown, Karah H.
    Guan, Tianyun
    Smith, Luke A.
    Formslag, Cole R.
    Farjado, Emerson D.
    Bai, Qian
    Luechtefeld, Harrison D.
    Wakefield, Mark R.
    Dong, Lijun
    Fang, Yujiang
    MEDICAL ONCOLOGY, 2023, 40 (07)
  • [42] Diagnostic Evaluation and Staging of Pancreatic Ductal Adenocarcinoma
    Mclntyre, Caitlin A.
    Winter, Jordan M.
    SEMINARS IN ONCOLOGY, 2015, 42 (01) : 19 - 27
  • [43] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    MINERVA SURGERY, 2024, : 315 - 325
  • [44] Updates in the Surgical Management of Pancreatic Ductal Adenocarcinoma
    Harrison, Julia
    Brauer, David G.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2025, 54 (01) : 223 - 243
  • [45] Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma
    Al Haddad, Amal H. I.
    Adrian, Thomas E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (11) : 1499 - 1515
  • [46] Preoperative Biopsy Is Not Associated With Adverse Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Upfront Resection
    Servin-Rojas, Maximiliano
    Bolm, Louisa
    Lillemoe, Keith D.
    Fong, Zhi Ven
    Narayan, Raja R.
    Castillo, Carlos Fernandez-Del
    Qadan, Motaz
    JOURNAL OF SURGICAL RESEARCH, 2025, 307 : 33 - 41
  • [47] Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
    Li, Huangbao
    Pan, Weiwei
    Xu, Liu
    Yin, Dong
    Cheng, Shuqun
    Zhao, Fengqing
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [48] Biomarkers in pancreatic ductal adenocarcinoma
    Gallego, J.
    Lopez, C.
    Pazo-Cid, R.
    Lopez-Rios, F.
    Carrato, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12) : 1430 - 1437
  • [49] Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size Positive Implications for Future Targeted Screening
    Hur, Chin
    Tramontano, Angela C.
    Dowling, Emily C.
    Brooks, Gabriel A.
    Jeon, Alvin
    Brugge, William R.
    Gazelle, G. Scott
    Kong, Chung Yin
    Pandharipande, Pari V.
    PANCREAS, 2016, 45 (07) : 1062 - 1066
  • [50] Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma
    Byrne, James D.
    Jajja, Mohammad R. N.
    Schorzman, Allison N.
    Keeler, Amanda W.
    Luft, J. Christopher
    Zamboni, William C.
    DeSimone, Joseph M.
    Yeh, Jen Jen
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (08) : 2200 - 2205
12345